Brain MRI follow-up with or without preventive scans in SCLC
Part of Brain & nervous system, Cancer clinical trials.
This study tests whether adding a preventive brain procedure (PCI) to standard follow-up brain MRIs helps people with limited-stage small-cell lung cancer stay disease-free longer. It compares “MRI only” versus “MRI plus PCI” after the cancer has fully responded to initial treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with small-cell lung cancer (SCLC) confirmed by lab tests.
- You are 18 years or older, and your daily functioning is fairly good (Karnofsky score 80 or higher).
- Your cancer stage is “limited-stage,” meaning it is mainly in one side of the chest with certain lymph node involvement, not widespread disease.
- After finish of chest radiation and chemotherapy, your scans showed complete remission within 4–6 weeks.
- You can attend follow-up visits and understand the study well enough to sign consent.
- You must be able to safely have brain MRI (no medical reasons you cannot get MRI).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether treating the main tumor alone, without the nearby lymph nodes, can work as well in limited-stage small cell lung cancer after initial chemotherapy. You may qualify if you have not had disease progression after 2-4 cycles of standard chemo and meet other health criteria.
This trial combines standard chemotherapy and radiation with two immunotherapy drugs (immune checkpoint inhibitors) to see if they work better together for people with limited-stage small cell lung cancer. It aims to improve outcomes without using strong immune-suppressing medicines.
This study compares two ways to follow and treat small-cell lung cancer in the brain: preventive brain radiation versus close monitoring with MRI scans and treatment only if needed. It may help people avoid unnecessary brain treatment or choose the safer timing strategy.
This trial compares two ways to manage limited-stage small cell lung cancer that has improved after initial chemotherapy and radiation. Participants will either get preventive brain radiation or have regular brain MRI scans instead, to see which approach is safer and works better.
This trial tests a new radiation approach for people with small cell lung cancer that has spread to the brain. It combines whole-brain radiation that avoids the memory centers, followed by focused radiation to the tumors, while you also receive standard chemotherapy and immunotherapy.
This study follows patients with small cell lung cancer who receive radiation therapy combined with other treatments. Researchers will track how well the treatment works and how patients respond over time to help improve future care.
Hear when a new Small Cell Lung Cancer Limited Stage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.